Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 7Neoplasms 7Carcinoma, Renal Cell 7Stomach Neoplasms 5Pancreatic Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lung Neoplasms 2Esthesioneuroblastoma, Olfactory 2Colonic Neoplasms 2Chondrosarcoma 2Carcinoma, Merkel Cell 2Carcinoma, Hepatocellular 2

Interventions

Radiotherapy 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Erlotinib Hydrochloride 1Drug Therapy 1Docetaxel 1Cisplatin 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parotid Neoplasms × Docetaxel × Dermatologic × Clear all
NCT00405405 2025-05-06

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

Thomas Jefferson University

Phase 1 Completed
13 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma, Parotid Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡